AI Software & Apps

17 tickers in this theme
Ranks this page's recent reports by score.
Clover Health Investments, Corp.
CLOV·Healthcare
S ★★★★★Strong Buy
Current$4.16
Target$6.50
Return+56.2%
Aug 25, 2026

Clover Health is a cash-generating AI pioneer shifting from distressed insurtech to high-margin value-based care software, though investors must watch legislative risk in CMS Medicare Advantage reimbursement and pending legal appeals.

Score
95
SoundHound AI, Inc.
SOUN·Technology
F Avoid
Current$7.32
Aug 24, 2026

SoundHound's proprietary voice AI and record revenue growth are outweighed by peer overvaluation, heavy roll-up dilution, collapsing gross margins and impending distressed-asset debt.

Score
29
AvePoint, Inc.
AVPT·Technology
A ★★★★Buy
Current$13.37
Target$17.00
Return+27.1%
Aug 24, 2026

AvePoint is a highly profitable, Rule of 40 cloud data management platform dominating the Microsoft ecosystem, offering a compelling compounding opportunity despite risks tied to ecosystem dependence and recent insider selling.

Score
86
Freshworks Inc.
FRSH·Technology
A ★★★★Buy
Current$13.07
Target$16.75
Return+28.2%
Aug 23, 2026

Freshworks is a highly profitable, AI-infused IT management disruptor trading at a deeply compressed free cash flow multiple, though investors must vigilantly monitor the intense competitive threat from mega-cap software incumbents.

Score
86
Palantir Technologies Inc.
PLTR·Technology
A ★★★★Buy
Current$162.66
Target$191.25
Return+17.6%
Aug 6, 2026

Palantir's sovereign and enterprise AI platform drives 149% commercial growth and 63% free cash flow margins, but extreme valuation and persistent stock-based dilution require tolerance.

Score
85